One of the hallmarks of lun
g cancer is chromosome instability (CIN), particularly a tetraploid phenotype,which is normally prevented by the spindle assembly checkpoint. Hexavalent chromium [Cr(VI)] is anestablished human lun
g carcino
gen, and Cr(VI) induces tumors at lun
g bifurcation sites where Cr(VI)particles impact and persist. However, the effects of Cr(VI) on the spindle assembly checkpoint areunknown and little is known about prolon
ged exposure to particulate Cr(VI). Accordin
gly, we investi
gatedparticulate Cr(VI)-induced bypass of the spindle assembly checkpoint after several days of exposure inWHTBF-6 cells. We found that lead chromate indeed induces spindle assembly checkpoint bypass inhuman lun
g cells, as 72, 96, and 120 h treatments with 0.5 or 1
![](/ima<font color=)
ges/entities/m
gr.
gif">
g/cm
2 lead chromate induced si
gnificantincreases in the percenta
ge of cells with aberrant mitotic fi
gures. For example, treatment with 1
![](/ima<font color=)
ges/entities/m
gr.
gif">
g/cm
2lead chromate for 96 h induced 11, 12.3, and 14% of cells with premature anaphase, centromere spreadin
gand premature centromere division, respectively. In addition, we found a disruption of mitosis with morecells accumulatin
g in anaphase; cells treated for 96 h increased from 18% in controls to 31% in cellstreated with lead chromate. To confirm involvement of the spindle assembly checkpoint, Mad2 expressionwas used as a marker. Mad2 expression was decreased in cells exposed to chronic treatments of leadchromate, consistent with disruption of the checkpoint. We also found concentration- and time-dependentincreases in tetraploid cells, which continued to
grow and form colonies. When cells were treated withchronic lead alone there was no increase in aberrant mitotic cells or polyploidy; however, chronic exposureto a soluble Cr(VI) showed an increase in aberrant mitotic cells and polyploidy. These data su
ggest thatlead chromate does induce CIN and may be one mechanism in the development of Cr(VI)-induced lun
gcancer.